Phibro Animal Health (NASDAQ:PAHC) Raised to Buy at BidaskClub

Share on StockTwits

BidaskClub upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a hold rating to a buy rating in a report released on Saturday, BidAskClub reports.

A number of other equities analysts also recently weighed in on the stock. Barclays assumed coverage on shares of Phibro Animal Health in a report on Tuesday, June 11th. They set an underweight rating and a $25.00 target price on the stock. Gabelli upgraded shares of Phibro Animal Health from a hold rating to a buy rating and set a $42.00 target price on the stock in a report on Wednesday, May 8th. They noted that the move was a valuation call. ValuEngine upgraded shares of Phibro Animal Health from a sell rating to a hold rating in a report on Thursday, May 23rd. Zacks Investment Research upgraded shares of Phibro Animal Health from a sell rating to a hold rating in a report on Monday, April 29th. Finally, Guggenheim assumed coverage on shares of Phibro Animal Health in a report on Thursday, May 23rd. They set a neutral rating on the stock. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. Phibro Animal Health has an average rating of Hold and a consensus target price of $41.50.

Shares of PAHC stock opened at $30.50 on Friday. The stock has a fifty day simple moving average of $30.62. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41. The company has a market capitalization of $1.25 billion, a price-to-earnings ratio of 17.53, a PEG ratio of 4.33 and a beta of 0.69. Phibro Animal Health has a 12 month low of $27.32 and a 12 month high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.39 EPS for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.04). The business had revenue of $205.70 million during the quarter, compared to the consensus estimate of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The business’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.46 EPS. As a group, equities analysts predict that Phibro Animal Health will post 1.52 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, September 3rd. This represents a $0.48 dividend on an annualized basis and a yield of 1.57%. Phibro Animal Health’s payout ratio is 27.59%.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Janus Henderson Group PLC increased its holdings in Phibro Animal Health by 315.4% during the second quarter. Janus Henderson Group PLC now owns 956,784 shares of the company’s stock worth $30,397,000 after buying an additional 726,444 shares during the last quarter. Ceredex Value Advisors LLC increased its holdings in shares of Phibro Animal Health by 5.8% in the first quarter. Ceredex Value Advisors LLC now owns 886,646 shares of the company’s stock valued at $29,260,000 after purchasing an additional 48,694 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Phibro Animal Health by 3.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 531,387 shares of the company’s stock valued at $17,089,000 after purchasing an additional 20,108 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Phibro Animal Health by 8.0% in the fourth quarter. Northern Trust Corp now owns 452,913 shares of the company’s stock valued at $14,566,000 after purchasing an additional 33,656 shares during the last quarter. Finally, FMR LLC increased its holdings in shares of Phibro Animal Health by 82.7% in the first quarter. FMR LLC now owns 337,652 shares of the company’s stock valued at $11,143,000 after purchasing an additional 152,853 shares during the last quarter. Institutional investors and hedge funds own 50.07% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Article: What does the Producer Price Index (PPI) tell investors?

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Adobe  Issues Quarterly  Earnings Results
Adobe Issues Quarterly Earnings Results
Aduro BioTech Inc  CEO Sells $40,738.38 in Stock
Aduro BioTech Inc CEO Sells $40,738.38 in Stock
Trilogy International Partners Inc  Senior Officer Buys C$41,976.00 in Stock
Trilogy International Partners Inc Senior Officer Buys C$41,976.00 in Stock
FedEx  Issues Quarterly  Earnings Results, Misses Expectations By $0.12 EPS
FedEx Issues Quarterly Earnings Results, Misses Expectations By $0.12 EPS
Insider Selling: World Acceptance Corp.  SVP Sells $57,670.20 in Stock
Insider Selling: World Acceptance Corp. SVP Sells $57,670.20 in Stock
Prophecy Development Corp  Director Sells C$46,000.00 in Stock
Prophecy Development Corp Director Sells C$46,000.00 in Stock


© 2006-2019 Ticker Report